Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

OTHER × IIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib Therapy × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 2067 Neoplasms 1519 Prostatic Neoplasms 1112 Lung Neoplasms 796 Carcinoma, Non-Small-Cell Lung 747 Colorectal Neoplasms 739 Leukemia, Myeloid, Acute 512 Pancreatic Neoplasms 510 Multiple Myeloma 488 Carcinoma, Hepatocellular 466 Brain Neoplasms 447 Neoplasm Metastasis 409 Head and Neck Neoplasms 377 Ovarian Neoplasms 368 Precursor Cell Lymphoblastic Leukemia-Lymphoma 367 Melanoma 361 Glioblastoma 340 Stomach Neoplasms 332 Squamous Cell Carcinoma of Head and Neck 319 Colonic Neoplasms 306 Uterine Cervical Neoplasms 304 Lymphoma 299 Recurrence 295 Sarcoma 284 Hematologic Neoplasms 282 Rectal Neoplasms 275 Glioma 255 Carcinoma, Renal Cell 252 Triple Negative Breast Neoplasms 249 Urinary Bladder Neoplasms 248

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡